Skip to main content
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

FDA Asks Federal Judge For Permission to Withhold Pfizer COVID-19 Jab Data Until 2076


While that headline seems like clickbait, it’s a legitimate request the FDA made to a federal judge.

The federal agency wants to withhold the full disclosure of the data and information of Pfizer’s COVID-19 injection for 55 years.

Yet, they have no qualms approving the experimental injection for children as young as 5 years of age.

With the few documents available, we know Pfizer admitted they need longer studies and a larger sample size to determine the safety profile for children.

And the latest revelations indicate Pfizer lied about the number of trial subjects that died after receiving the experimental COVID-19 injection.

Alex Berenson reported the findings in Unreported Truths:

The one-paragraph summary: Pfizer told the world 15 recipients of Comirnaty had died in its pivotal trial. The real number was 21 – compared to only 17 people who didn’t get the shot.

That’s an incriminating piece of evidence Pfizer and the FDA chose not to disclose before the rollout of the experimental injection to millions of people.

As I reported Tuesday, a search through the VAERS database on the CDC website resulted in 2.3 million adverse events for the Pfizer COVID-19 jab alone.

What other information about the Pfizer COVID-19 jab is so incriminating that the FDA wants to withhold from the public until 2076?

In the United States District Court for the Northern District of Texas, Public Health and Medical Professionals for Transparency issued a “FOIA” request for the full disclosure of data and information of the Pfizer COVID-19 jab.

The plaintiff requested the FDA provide the non-exempt portions of the information in four months.

But the FDA requested a slower rate of processing the 329,000+ pages of data produced by Pfizer.

The FDA proposed a processing rate of 500 pages per month.

For 329,000 pages, the FDA’s proposed rate would take a minimum of 658 months (55 years).

From the Second Joint Report:

After the December 1 production, FDA proposes to work through the list of documents that Plaintiff requested FDA prioritize for production in order of priority and process and release the non-exempt portions of those records to Plaintiff on a rolling basis. FDA proposes to process and produce the non-exempt portions of responsive records at a rate of 500 pages per month. This rate is consistent with processing schedules entered by courts across the country in FOIA cases.3 Plaintiff’s request (as set forth below) that FDA process and produce the non-exempt portions of more than 329,000 pages in four months would force FDA to process more than 80,000 pages per month. Undersigned counsel is not aware of any court ever granting such a request. The Court should decline to enter Plaintiff’s schedule for numerous reasons.

My interpretation of this request is that the FDA didn’t thoroughly read the data produced by Pfizer before granting approval of the experimental injection.

Aaron Siri brilliantly captured this hypocrisy in Injecting Freedom:

It took the FDA precisely 108 days from when Pfizer started producing the records for licensure (on May 7, 2021) to when the FDA licensed the Pfizer vaccine (on August 23, 2021).   Taking the FDA at its word, it conducted an intense, robust, thorough, and complete review and analysis of those documents in order to assure that the Pfizer vaccine was safe and effective for licensure. While it can conduct that intense review of Pfizer’s documents in 108 days, it now asks for over 20,000 days to make these documents available to the public.

So, let’s get this straight. The federal government shields Pfizer from liability.  Gives it billions of dollars.  Makes Americans take its product.  But won’t let you see the data supporting its product’s safety and efficacy.  Who does the government work for?


Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Hey, Noah here!

Wondering where we went?

Read this and bookmark our new site!

See you over there!

Thanks for sharing!